Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Cardiovasc Pharmacol ; 59(3): 241-8, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22030894

RESUMEN

Low concentrations of a hydrophilic nitric oxide donor (NOD) are reported to reduce myocardial reperfusion injury only when combined with a lipophilic antioxidant (AOX) to form a hybrid molecule (HYB). Here we tested whether liposoluble NOD requires to be combined with AOX to be protective. Isolated rat hearts underwent 30 minutes of ischemia and 120 minutes of reperfusion. To induce postconditioning, 1 µM solutions of the following liposoluble compounds were given during the first 20 minutes of reperfusion: NOD with weak (w-NOD) or strong NO-releasing potency (s-NOD); weak HYB built up with w-NOD and a per se ineffective AOX lead; strong HYB built up with s-NOD and the same AOX; mixtures of w-NOD plus AOX or s-NOD plus AOX. A significant reduction of infarct size with improved recovery of cardiac function was obtained only with weak HYB. We suggest that w-NOD requires the synergy with a per se ineffective AOX to protect. The synergy is possible only if the 2 moieties enter the cell simultaneously as a hybrid, but not as a mixture. It seems that strong HYB was ineffective because an excessive intracellular NO release produces a large amount of reactive species, as shown from the increased nitrotyrosine production.


Asunto(s)
Antioxidantes/farmacología , Cardiotónicos/farmacología , Daño por Reperfusión Miocárdica/prevención & control , Donantes de Óxido Nítrico/farmacología , Animales , Antioxidantes/administración & dosificación , Antioxidantes/química , Cardiotónicos/administración & dosificación , Cardiotónicos/química , Sinergismo Farmacológico , Poscondicionamiento Isquémico/métodos , Masculino , Infarto del Miocardio/fisiopatología , Infarto del Miocardio/prevención & control , Daño por Reperfusión Miocárdica/fisiopatología , Óxido Nítrico/metabolismo , Donantes de Óxido Nítrico/administración & dosificación , Donantes de Óxido Nítrico/química , Ratas , Ratas Wistar , Tirosina/análogos & derivados , Tirosina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA